BIRICODAR (VX-710; Incel(TM)): An effective chemosensitizer in neorublastoma

British Journal of Cancer

Volumn 80, Issue 8, 1999, Pages 1190-1196

  Yanagisawa, T ^a   Newman, A ^a   Coley, H ^a   Renshaw, J ^a   Pinkerton, C R ^a   Pritchard Jones, K ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIRICODAR; CYCLOSPORIN A; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PIPECOLIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VALSPODAR; VINCRISTINE;

ARTICLE; CHEMOSENSITIVITY; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MULTIDRUG RESISTANCE; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; HUMANS; ISOENZYMES; NEUROBLASTOMA; P-GLYCOPROTEIN; PIPERIDINES; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; VINCRISTINE;

EID: 0032989872     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6990485     Document Type: Article

References (29)

1. Beck WT, Grogan TM, Willman CL, Cordon Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HS, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ and Srivastava DK (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res 56: 3010-3020
2. Beck WT, Handgretinger R, Dopfer R, Klingebiel T, Niethanmmer D and Gekeler V (1995) Expression of MDR1, MRP, topoisomerase Iia/b, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias. Br J Haematol 89: 356-363
3. Beketic-Oreskovic L, Duran GE, Chen G, Dumontet G and Sikie BI (1995) Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. J Natl Cancer Inst 87: 1593-1602
4. Biedler JL and Spengler BA (1976) Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science 191: 185-187
5. Biedler JL, Helson L and Spengler BA (1973) Morphology and growth, tumorigenicity and cytogeneties of human neuroblastoma cells in continuous culture. Cancer Res 33: 2652
6. Boote DJ, Dennis IF, Twentyman PR, Osborne RJ, Laburte C, Hensel S, Smyth JF, Brampton MH and Bleehen NM (1996) Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer. J Clin Oncol 14: 610-618
7. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM and Norris MD (1994) Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 54: 5036-5040
8. Bourhis J, Benard J, Hartmann O, Boccon Gibod L, Lemerle J and Riou G (1989) Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst 81: 1401-1405
9. Cairo MS, Siegel S, Anas N and Sender L (1989) Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors. Cancer Res 49: 1063-1066
10. Chan HS, Haddad G, Thomer PS, DeBoer G, Lin YP, Ondrusek N, Yeger H and Ling V (1991) P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 325: 1608-1614
11. Chan HS, DeBoer G, Haddad G, Gallie BL and Ling V (1995) Multidrug resistance in pediatric malignancies. Hematol Oncol Clin North Am 9: 275-318
12. Cowie F and Pinkerton CR (1994) Enhanced toxicity of dactinomycin and vincristine by cyclosporine given in reverse multidrug resistance [letter]. J Clin Oncol 12: 1998-1999
13. Cowie FJ, Pinkerton CR, Phillips M, Dick G, Judson I, McCarthy PT and Flanagan RJ (1995) Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers. Br J Cancer 71: 877-881
14. Deacon JM (1986) The radiobiology of human neuroblastoma. (A thesis submitted in the University of London for the degree of Doctor of Medicine).
15. Feller N, Kuiper CM, Lankelma J, Ruhdal JK, Scheper RJ, Pinedo HM and Broxterman HJ (1995) Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. Br J Cancer 72: 543-549
16. Futscher BW, Blake LL, Gerlach JG, Grogan TM and Dalton WS (1993) Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple mycloma cell lines and clinical specimens. Analyst Biochem 213: 421
17. Germann UA, Shlyakher D, Mason VS, Zelle RE, Duffy JP, Galullo V, Atmistead DM, Saunders JO, Boger J and Harding MW (1997a) Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro. Anti-Cancer Drugs 8: 125-140
18. Germann UA, Ford PJ, Shlyakher D, Mason VS and Harding MW (1997b) Chemosensilization and drug accummulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP. Anti-Cancer Drugs 8: 141-155
19. Goodwin CJ, Holt SJ, Downes S and Marshall NJ (1995) Microculture tetrazolium assays: a comparison between two new tetrazolium salts. XTT and MTS. J Immunol Methods 179: 95-103
20. Helson C, Zahn Z and Helson L (1994) Reversion of P-glycoprotein mediated multidrug resistance to vincristine and adriamycin by PSC 833, a cyclosporine derivative in human neuroblastoma cell lines. Int J Oncol 5: 1037-1042
21. Hills CA, Kelland LR, Abel G, Siracky J, Wilson AP and Harrap KR (1989) Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes. Br J Cancer 59: 527-534
22. Inui A (1974) Catecholamine metabolism in a continuous human neuroblastoma cell line (NB-1). Establishment of a continuous cell line (NB-1) and comparative study on catecholamine metabolism in neuroblastoma in vivo and in vitro. Acta Pediatr Jpn 78: 977-989
23. Lum BL, Fisher GA, Brophy NA, Yahanda AM, Adler KM, Kaubisch S, Halsey J and Sikic BI (1993) Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations. Cancer 72: 3502-3514
24. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL and Haber M (1996) Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. New England Journal of Medicine 334: 231-238
25. Peck R, Marshall JL, Ziessman HA, et al. (1995) Preliminary findings from a phase I/II trial of doxorubicin (DOX) and VX-710. [Abstract] AACR, Special Conference in Cancer Research: Novel Strategies Against Resistant Cancers
26. Pike BL and Robinson WA (1970) Human bone marrow colony growth in agar-gel. J Cell Physiol 76: 77-84
27. Rowinsky EK, Smith I, Wang YM et al (1998) Phase I and pharmacokinetic study of paclitaxel in combination with Biricodar, a Novel Agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP. J Clin Oncol 16: 2964-2976
28. Stein U, Walther W, Laurencot CM, Scheffer GL, Scheper RL and Shoemaker RH (1997) Tumor necrosis factor-α and expression of the multidrug resistance associated genes LRP and MRP. J Natl Cancer Inst 89: 807-813
29. Tumilowicz JJ, Nichols WW, Cholon JJ and Greene AE (1970) Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 30: 2110-2118